Efferent pathways of the cardiovascular response to vertebral artery infusions of angiotensin in the dog.
D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001949:Bretylium Compounds / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects*; D004285:Dogs; D006146:Guanidines / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D007269:Injections, Intra-Arterial; D009474:Neurons / Q000187:drug effects*; D009476:Neurons, Efferent / Q000187:drug effects; D011311:Pressoreceptors / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects; D014628:Vagotomy; D014630:Vagus Nerve / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects; D014711:Vertebral Artery
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D006146:Guanidines; D000804:Angiotensin II; D001285:Atropine; D011433:Propranolol